Investment Manager Loads CELC Stock: Fresh Insight for 2025
A noteworthy fund increased its Celcuity stake by 135,000 shares, signaling potential catalysts and shifting risk. Le...
Biotech Investing
On this Biotech Investing tag page, 5 recent articles cover innovative biotech stocks, Agios moves, Arcellx updates, Cogent Biosciences and more, giving you quick, actionable finance insights.
109 articlesDon't Even Think About Regencell Stock Until You See Flag
Regencell Bioscience sits in the high-risk, high-reward world of early-stage biotech. Before you consider investing, ...
Liquidia (LQDA) 2025 Earnings: Key Takeaways for Investors
As Liquidia releases its Q4 2025 results, investors crave clarity on revenue, burn rate, and milestones. This article...
Verastem (VSTM) 2025 Earnings Outlook for Investors
As Verastem prepares for its 2025 earnings outlook, investors should focus on cash runway, collaboration milestones, ...
Investment Advisor Bets CMPX Stock: Big Stake Signals Conviction
A prominent investment advisor added a sizable CMPX position, signaling strong conviction in Compass Therapeutics. He...
Compugen (CGEN) 2025 Earnings Outlook for Investors
A forward-looking look at Compugen's 2025 earnings. Learn how pipeline progress, partnerships, and cash runway could ...
Therapeutics (TGTX) 2025 Earnings Outlook for Investors
TG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Disc Medicine Lands Million: Investors React to FDA Catalyst
A private equity firm just disclosed a sizable stake in Disc Medicine, signaling growing confidence in its red blood ...
Disc Medicine Stock Swinging, Yet a Fund Bet Shines
A leading hedge fund just disclosed a sizable new stake in Disc Medicine. This article breaks down what Disc Medicine...
Here's Grail Stock Bounced: Why the Rebound Today
Grail stock showed a notable bounce after several tough sessions tied to trial updates. This piece breaks down what’s...
Stock Market Today, Feb.: ImmunityBio Surges on Anktiva
Biotech headlines move markets. ImmunityBio, boosted by Anktiva's 700% revenue surge, sparked a rally that may signal...
Stock Market Today, Feb. Focus: Novo Nordisk Slump Sends Ripples
A major biotech setback on Feb. 23 spooked investors and nudged major indices lower. This piece breaks down what happ...
Related Topics
#Stock Analysis (25)
#Earnings Analysis (22)
#Portfolio Management (15)
#Portfolio Strategy (13)
#Stock Market (12)
#Investing (10)
#Insider Trading (10)
#risk-management (8)
#Hedge Funds (7)
#Earnings (5)
#Healthcare Stocks (5)
#SEC Filings (5)
#Investment Strategy (4)
#Stock Market News (4)
#Small-Cap Stocks (4)